- CSR Summary Not Yet Available
- NCT01050582
- Primary Citation Not Available
- Data Specification Not Available
Trial Information
Generic NameRisperidoneProduct NameRISPERDAL®Therapeutic AreaBehaviors and Mental DisordersEnrollment244% Female18.5%% White79.3%
Product ClassAtypical AntipsychoticsSponsor Protocol NumberRISNAP4022Data PartnerJohnson & JohnsonCondition StudiedSchizophreniaMean/Median Age (Years)12
Supporting Documentation
- Collected Datasets Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available
Approved Data Requests Associated with this Trial
- 2022-4992 : Temporal trajectories of side-effects associated with antipsychotic treatment ? An individual participant data meta-analysis
- 2021-4754 : Harnessing clinical trial data to inform real-world clinical decision making in the treatment of schizophrenia
- 2019-3958 : Machine Learning for predicting treatment efficacy and clinical categorizations across mental health disorders.